ONP [Orient Paper] DEF 14A: (Original Filing)
[]
SOL [ReneSola] 6-K: ReneSola Receives Notice Regarding NYSE Listing Criteria and
[ReneSola Receives Notice Regarding NYSE Listing Criteria and Enters Into Term Sheet with Respect to Potential Disposition of Certain Businesses and Liabilities www.renesola.com SHANGHAI, August 26, 2017 /PRNewswire/ ReneSola Ltd (“ReneSola” or the “Company”) ( The Company is considered below criteri]
BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, August 28, 2017 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on August 22,]
BSPM [Biostar Pharmaceuticals] 8-K: Biostar Announces Receipt of Nasdaq Continued Listing Deficiency
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, August 28, 2017 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on August 22,]
JFC [JPMORGAN CHINA REGION FUND] NSAR-A: (Original Filing)
[Item 77c An Annual Meeting of Shareholders was held on June 14, 2016. Shareholders voted to elect Trustees of the Fund to hold office for a term of three years or until their respective successors shall have been duly elected and qualified. The following votes were cast with respect to each of the n]
